Emma Shtivelman
- Molecular Biology top 5%
- Hematology top 0.5%
- Oncology top 5%
- Genetics top 1%
- Cancer Research top 5%
- Co-authors
- Eli CanaaniRobert Peter GaleJ. Michael BishopBruce A. RoeDavid StokoeIsaac CohenFrank W. KingMary Tagliaferri
- Topics
- Ubiquitin and proteasome pathways (7 papers)Neuroblastoma Research and Treatments (5 papers)RNA modifications and cancer (5 papers)
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Emma Shtivelman
42 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Molecular Biology 2.4k
- Hematology 1.4k
- Oncology 931
- Genetics 903
- Cancer Research 602
Countries citing papers authored by Emma Shtivelman
This map shows the geographic impact of Emma Shtivelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Shtivelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Shtivelman more than expected).
Fields of papers citing papers by Emma Shtivelman
This network shows the impact of papers produced by Emma Shtivelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Shtivelman. The network helps show where Emma Shtivelman may publish in the future.
Co-authorship network of co-authors of Emma Shtivelman
This figure shows the co-authorship network connecting the top 25 collaborators of Emma Shtivelman. A scholar is included among the top collaborators of Emma Shtivelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Shtivelman. Emma Shtivelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 40 | |
| 2 | 41 | |
| 3 | 22 | |
| 4 | 75 | |
| 5 | 8 | |
| 6 | 74 | |
| 7 | 38 | |
| 8 | 84 | |
| 9 | 45 | |
| 10 | 16 | |
| 11 | 154 | |
| 12 | 51 | |
| 13 | 33 | |
| 14 | 80 | |
| 15 | 11 | |
| 16 | 26 | |
| 17 | 17 | |
| 18 | 36 | |
| 19 | 80 | |
| 20 | 84 |
About Emma Shtivelman
Emma Shtivelman is a scholar working on Molecular Biology, Cancer Research and Hematology, having authored 42 papers that have together received 4.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (7 papers), Neuroblastoma Research and Treatments (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (903 citations) and Cancer Research (602 citations). Emma Shtivelman has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Eli Canaani, Robert Peter Gale, J. Michael Bishop, Bruce A. Roe, David Stokoe, Isaac Cohen, Frank W. King, Mary Tagliaferri, Fred E. Cohen and Sylvia Fong. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.